The increase in LC3 concentration in the DLB frontal cortex compared to that CTRL is in agreement with previous evidence showing an increase in LC3-II in DLB brain specimens and in transgenic mice overexpressing mutant α-synuclein. This evidence concerns the gene MAP1LC3A and Lewy body dementia.